MRVI MARAVAI LIFESCIENCES HOLDIN...

Nasdaq maravai.com


$ 3.23 $ -0.07 (-2.12 %)    

Tuesday, 14-Oct-2025 15:59:58 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 3.23
$ 3.21
$ 2.80 x 1,000
$ 3.40 x 1,000
$ 3.20 - $ 3.33
$ 1.67 - $ 8.54
1,293,051
na
824.82M
$ 0.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-11-2025 06-30-2025 10-Q
2 05-12-2025 03-31-2025 10-Q
3 03-18-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-29-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 02-28-2023 12-31-2022 10-K
12 11-04-2022 09-30-2022 10-Q
13 08-05-2022 06-30-2022 10-Q
14 05-06-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
18 05-12-2021 03-31-2021 10-Q
19 03-22-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rbc-capital-maintains-outperform-on-maravai-lifesciences-lowers-price-target-to-5

RBC Capital analyst Conor McNamara maintains Maravai LifeSciences (NASDAQ:MRVI) with a Outperform and lowers the price targe...

 maravai-lifesciences-q2-adj-eps-008-misses-007-estimate-sales-4740m-inline

Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate o...

 maravai-lifesciences--announces-the-appointment-of-bernd-brust-as-chief-executive-officer-effective-immediately

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and b...

 trilink-biotechnologies-releases-its-first-mrna-synthesis-kit-with-cleancap-capping-technology

New all-in-one IVT kit can deliver up to 2X more mRNA and up to 85% lower dsRNA compared to other kits on the market through st...

 trilink-and-ivi-collaborate-to-advance-research-and-development-of-mrna-based-vaccines-and-promote-equitable-access-to-essential-vaccines-and-health-technologies

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ:MRVI) and global provider of life science reagents ...

 craig-hallum-maintains-buy-on-maravai-lifesciences-lowers-price-target-to-10

Craig-Hallum analyst Christian Schwab maintains Maravai LifeSciences (NASDAQ:MRVI) with a Buy and lowers the price target fr...

 baird-maintains-neutral-on-maravai-lifesciences-lowers-price-target-to-2

Baird analyst Catherine Schulte maintains Maravai LifeSciences (NASDAQ:MRVI) with a Neutral and lowers the price target from...

 maravai-lifesciences-q1-adj-eps-008-misses-007-estimate-sales-4685m-beat-4401m-estimate

Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate o...

 morgan-stanley-maintains-equal-weight-on-maravai-lifesciences-lowers-price-target-to-5

Morgan Stanley analyst Tejas Savant maintains Maravai LifeSciences (NASDAQ:MRVI) with a Equal-Weight and lowers the price ta...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION